Stevanato doubles down on pen injector tech
To view this email as a web page, click here

Today's Rundown

Featured Story

VCs infuse $215M into Sanofi-backed wearable subcutaneous drug delivery player Enable Injections

Sanofi-backed Enable Injections has gone big with its series C round. Three years after Sanofi led its series B, Enable Injections has raised a $215 million round to fund work on subcutaneous drug delivery system enFuse.

read more

Top Stories

Sherblom's Comera inks SPAC merger to fund subcutaneous delivery programs

Jim Sherblom’s Comera Life Sciences has inked a SPAC merger. The subcutaneous delivery specialist is set to generate around $107 million through the deal to fund work on partnerships and internal programs.

read more

Stevanato doubles down on pen injector technology, expanding into indications beyond diabetes

Stevanato is doubling down on Haselmeier’s Axis-D pen injector technology. Having originally licensed the delivery technology in diabetes, Stevanato has now bagged the rights to use it across a wide range of therapeutic areas.

read more

West and Corning team up for injectable drug delivery project

West Pharmaceutical Services is hooking up with Corning. As part of an exclusive long-term deal, West is making a multimillion-dollar capital and R&D investment in its new partner to advance drug delivery. 

read more

Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron's dominant Eylea

With an FDA approval for Vabysmo to treat wet-age related macular degeneration (AMD) and diabetic macular edema (DME), Genentech and Roche have an antibody drug that could challenge Regeneron and Bayer's Eylea. The key edge for Vabysmo is that for most patients, it would allow fewer injections.

read more

Resources

Whitepaper: The CNS Market: 2021 Year in Review & Outlook for 2022

What’s in store for the CNS therapeutics market in 2022? This paper looks ahead in Alzheimer’s, Parkinson’s, DMD, psychiatric disorders, pain, and more.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific.

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific.

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events